neostigmine (Compound)

Synonyms:NEOSTIGMINE, Eustigmin, Eustigmine, Prostigmine, 59-99-4, Vagostigmine, Prostigmin, Juvastigmin, m-Trimethylammoniumphenyldimethylcarbamate, Neostigmine [BAN], 3-Trimethylammoniumphenyl N,N-dimethylcarbamate, Neostigmine ion, Neostigmine cation, 3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium, Neostigmine (BAN), Neostigmine (cation), (m-Hydroxyphenyl)trimethylammonium dimethylcarbamate, Prostigmin (TN), [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium, Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-, CHEBI:7514, CHEMBL278020, Neostigmin, Neostigminum, 3982TWQ96G, [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium bromide, 3-{[(dimethylamino)carbonyl]oxy}-N,N,N-trimethylanilinium, 3-((dimethylcarbamoyl)oxy)-N,N,N-trimethylbenzenaminium, Benzenaminium, 3-[[(dimethylamino)carbonyl]oxy]-N,N,N-trimethyl-, [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium; sulfonatooxymethane, CCRIS 3079, HSDB 3921, NCGC00163240-01, CAS-114-80-7, BRN 3615946, UNII-3982TWQ96G, (m-Hydroxyphenyl)trimethylammonium dimethylcarbamate (ester), Ammonium, (m-hydroxyphenyl)trimethyl-, dimethylcarbamate (ester), Spectrum_001061, NEOSTIGMINE [MI], Prestwick0_000468, Prestwick1_000468, Prestwick2_000468, Prestwick3_000468, Spectrum2_001278, Spectrum4_000072, Spectrum5_001234, Lopac-N-2001, NEOSTIGMINE [HSDB], bmse000762, NEOSTIGMINE [VANDF], NEOSTIGMINE [MART.], Lopac0_000816, SCHEMBL34419, BSPBio_000576, KBioGR_000623, KBioSS_001541, [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium, DivK1c_000165, DivK1c_000198, SPBio_001276, SPBio_002515, BPBio1_000634, GTPL8993, DTXSID1023360, ALWKGYPQUAPLQC-UHFFFAOYSA-, KBio1_000165, KBio1_000198, KBio2_001541, KBio2_004109, KBio2_006677, NINDS_000165, NINDS_000198, HMS2089A22, BDBM50022775, STL058953, AKOS005711366, CCG-204900, DB01400, IDI1_000165, IDI1_000198, MLS-0002855, NCGC00015730-01, NCGC00015730-02, NCGC00015730-03, NCGC00015730-04, NCGC00015730-05, NCGC00015730-06, NCGC00015730-07, NCGC00015730-08, NCGC00015730-09, NCGC00015730-24, NCGC00021658-03, SBI-0050793.P004, AB00053807, C07258, D08261, AB00053807-25, AB00053807-26, AB00053807_27, AB00053807_28, AB00053807_29, Q410546, BRD-K18922609-004-04-1, BRD-K18922609-004-14-0

Pubchem:PUBCHEM:4456

Id:e3d8525b-8753-54ad-9419-908710edc152

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View neostigmine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for neostigmine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with neostigmine.

Results found

Linked to

	Label	Description
	BRD-K18922609-004-14-0 Substance (Entity type)	A Substance
	neostigmine (a351ceaf-b838-471e-bafd-88d43f5e08e9) Collection (Entity type)	Metadatata for neostigmine
	DCSTRUCT ID 01897 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01897; PubChem_CID:4456, FILE=drugcentral_drug_01897.json)
	neostigmine positively regulates ZFPM2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	neostigmine negatively regulates BASP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	neostigmine negatively regulates PI3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	neostigmine positively regulates SNAP25 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	neostigmine negatively regulates TFPI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	neostigmine positively regulates TYMS Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	neostigmine positively regulates HOXB6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS